Mydecine Innovations Group Inc. (MYCOF)
OTCMKTS · Delayed Price · Currency is USD
0.1308
-0.0874 (-40.05%)
At close: Jan 5, 2026

MYCOF Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
00162962
Upgrade
Market Cap Growth
-65.58%-77.92%-85.99%-80.55%-53.51%1508.62%
Upgrade
Enterprise Value
55592862
Upgrade
Last Close Price
0.130.140.7421.50275.50875.00
Upgrade
PS Ratio
----4856.3430117.46
Upgrade
PB Ratio
-0.01-0.02-0.09-5.90172.2022.14
Upgrade
P/TBV Ratio
----172.2022.14
Upgrade
EV/Sales Ratio
----4702.8230027.99
Upgrade
Debt / Equity Ratio
-0.46-0.46-0.45-3.7321.300.90
Upgrade
Asset Turnover
----0.000
Upgrade
Quick Ratio
0.000.000.021.260.580.39
Upgrade
Current Ratio
0.000.000.021.471.770.43
Upgrade
Return on Equity (ROE)
-----1250.41%-997.41%
Upgrade
Return on Assets (ROA)
846.80%-1181.22%-124.30%-117.75%-163.15%-123.11%
Upgrade
Return on Capital Employed (ROCE)
-10.10%16.70%78.80%-463.90%-482.00%-306.20%
Upgrade
Earnings Yield
1015.72%-1266.95%-2025.06%-122.21%-79.41%-34.19%
Upgrade
FCF Yield
--15.00%-407.69%-111.36%-66.90%-9.41%
Upgrade
Buyback Yield / Dilution
-9.08%-94.24%-254.98%-84.71%-105.85%-
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.